InsiderClue
Stocks · Health care · Pharmaceutical Preparations

UroGen Pharma Ltd.

URGN Clue Score37
Israel Fiscal year ends December CIK 0001668243
$36.83 -0.41% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $36.83 +131.64% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 4 May 2017. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue17.5Operating income0.8Net income−1.9Fiscal year 2017Revenue8.2 −53.5%Operating income−20.0Net income−20.0Fiscal year 2018Revenue1.1 −86.2%Operating income−77.2Net income−75.7Fiscal year 2019Revenue0.0 −98.4%Operating income−109.5Net income−105.1Fiscal year 2020Revenue11.8 +65,450.0%Operating income−126.7Net income−128.5Fiscal year 2021Revenue48.0 +307.2%Operating income−92.3Net income−110.8Fiscal year 2022Revenue64.4 +34.0%Operating income−79.0Net income−109.8Fiscal year 2023Revenue82.7 +28.5%Operating income−65.5Net income−102.2Fiscal year 2024Revenue90.4 +9.3%Operating income−96.8Net income−126.9Fiscal year 2025Revenue109.8 +21.4%Operating income−124.9Net income−153.5
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 17.5 8.2 1.1 0.0 11.8 48.0 64.4 82.7 90.4 109.8
Growth −53.5% −86.2% −98.4% +65,450.0% +307.2% +34.0% +28.5% +9.3% +21.4%
Operating income 0.8 −20.0 −77.2 −109.5 −126.7 −92.3 −79.0 −65.5 −96.8 −124.9
Net income −1.9 −20.0 −75.7 −105.1 −128.5 −110.8 −109.8 −102.2 −126.9 −153.5
Growth

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2016Gross margin99.8%Operating margin4.6%Net margin−11.1%Free cash flow margin19.9%Fiscal year 2017Gross margin92.6%Operating margin−244.5%Net margin−245.2%Free cash flow margin−120.6%Fiscal year 2018Gross margin−59.8%Operating margin−6,842.2%Net margin−6,707.2%Free cash flow margin−3,359.4%Fiscal year 2019Gross margin100.0%Operating margin−608,211.1%Net margin−584,144.4%Free cash flow margin−396,344.4%Fiscal year 2020Gross margin91.4%Operating margin−1,074.2%Net margin−1,088.9%Free cash flow margin−907.7%Fiscal year 2021Gross margin89.3%Operating margin−192.1%Net margin−230.7%Free cash flow margin−178.3%Fiscal year 2022Gross margin88.1%Operating margin−122.8%Net margin−170.6%Free cash flow margin−136.4%Fiscal year 2023Gross margin88.7%Operating margin−79.2%Net margin−123.6%Free cash flow margin−92.6%Fiscal year 2024Gross margin90.2%Operating margin−107.1%Net margin−140.4%Free cash flow margin−107.4%Fiscal year 2025Gross margin88.7%Operating margin−113.7%Net margin−139.8%Free cash flow margin−148.2%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin 99.8% 92.6% −59.8% 100.0% 91.4% 89.3% 88.1% 88.7% 90.2% 88.7%
Operating margin 4.6% −244.5% −6,842.2% −608,211.1% −1,074.2% −192.1% −122.8% −79.2% −107.1% −113.7%
Net margin −11.1% −245.2% −6,707.2% −584,144.4% −1,088.9% −230.7% −170.6% −123.6% −140.4% −139.8%
Free cash flow margin 19.9% −120.6% −3,359.4% −396,344.4% −907.7% −178.3% −136.4% −92.6% −107.4% −148.2%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow4.2Capital expenditure−0.7Free cash flow3.5Fiscal year 2017Operating cash flow−9.6Capital expenditure−0.3Free cash flow−9.8 −381.6%Fiscal year 2018Operating cash flow−37.3Capital expenditure−0.6Free cash flow−37.9Fiscal year 2019Operating cash flow−71.0Capital expenditure−0.3Free cash flow−71.3Fiscal year 2020Operating cash flow−105.9Capital expenditure−1.2Free cash flow−107.1Fiscal year 2021Operating cash flow−84.9Capital expenditure−0.8Free cash flow−85.6Fiscal year 2022Operating cash flow−87.6Capital expenditure−0.3Free cash flow−87.8Fiscal year 2023Operating cash flow−76.4Capital expenditure−0.2Free cash flow−76.6Fiscal year 2024Operating cash flow−96.8Capital expenditure−0.3Free cash flow−97.1Fiscal year 2025Operating cash flow−162.4Capital expenditure−0.3Free cash flow−162.7
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow 4.2 −9.6 −37.3 −71.0 −105.9 −84.9 −87.6 −76.4 −96.8 −162.4
Capital expenditure −0.7 −0.3 −0.6 −0.3 −1.2 −0.8 −0.3 −0.2 −0.3 −0.3
Free cash flow 3.5 −9.8 −37.9 −71.3 −107.1 −85.6 −87.8 −76.6 −97.1 −162.7
Growth −381.6%

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash21.4Shareholders’ equity16.3Fiscal year 2017Cash37.0Shareholders’ equity68.5Fiscal year 2018Cash101.3Shareholders’ equity90.1Fiscal year 2019Cash49.7Shareholders’ equity180.3Fiscal year 2020Cash52.9Shareholders’ equity96.4Fiscal year 2021Cash44.4Total debt0.0Net cash (debt)44.4Shareholders’ equity8.4Debt to equity0.00Fiscal year 2022Cash55.4Total debt97.5Net cash (debt)−42.1Shareholders’ equity−89.4Fiscal year 2023Cash95.0Total debt98.6Net cash (debt)−3.5Shareholders’ equity−65.2Fiscal year 2024Cash172.0Total debt121.7Net cash (debt)50.3Shareholders’ equity−8.8Fiscal year 2025Cash110.7Total debt122.2Net cash (debt)−11.5Shareholders’ equity−105.5
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 21.4 37.0 101.3 49.7 52.9 44.4 55.4 95.0 172.0 110.7
Total debt n/a n/a n/a n/a n/a 0.0 97.5 98.6 121.7 122.2
Net cash (debt) n/a n/a n/a n/a n/a 44.4 −42.1 −3.5 50.3 −11.5
Shareholders’ equity 16.3 68.5 90.1 180.3 96.4 8.4 −89.4 −65.2 −8.8 −105.5
Debt to equity n/a n/a n/a n/a n/a 0.00 n/a n/a n/a n/a

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Balance sheet

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Assets
21.4 37.0 101.3 49.7 52.9 44.4 55.4 95.0 172.0 110.7
0.1 n/a n/a n/a 7.0 11.7 12.7 15.4 20.3 33.1
0.1 0.3 n/a n/a 2.0 4.8 4.3 5.7 9.2 16.5
0.7 0.8 0.9 1.0 2.0 2.0 1.3 0.7 0.7 0.6
23.1 75.6 103.6 202.4 122.0 119.7 135.6 178.3 285.7 200.5
Growth +227.7% +37.1% +95.4% −39.7% −1.9% +13.3% +31.5% +60.2% −29.8%
Liabilities
n/a n/a n/a n/a n/a 0.0 97.5 98.6 121.7 122.2
calc n/a n/a n/a n/a n/a 0.0 97.5 98.6 121.7 122.2
6.7 7.0 13.5 22.1 25.7 111.3 225.0 243.5 294.5 305.9
Equity
−27.2 −47.2 −122.9 −228.0 −356.5 −467.3 −577.1 −679.3 −806.2 −959.7
16.3 68.5 90.1 180.3 96.4 8.4 −89.4 −65.2 −8.8 −105.5
Growth +320.2% +31.5% +100.1% −46.6% −91.3% −1,162.2%
Per share and net cash
calc n/a n/a n/a n/a n/a 44.4 −42.1 −3.5 50.3 −11.5
2.3 13.8 16.2 21.0 22.2 22.5 23.1 32.5 42.2 48.4
calc 7.07 4.98 5.56 8.58 4.35 0.37 −3.86 −2.01 −0.21 −2.18

Lines marked calc are worked out here from filed figures; point at one for how.